Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rare Cannabinoid Company is a Hawaii-based wellness and consumer health company that specializes in the isolation and formulation of minor cannabinoids for targeted therapeutic benefits. The company provides a comprehensive range of products, including tinctures, gummies, and topicals, featuring specific compounds such as THCV for energy and appetite suppression, CBN for sleep, and CBG for inflammation. Their business model focuses on high-purity, lab-verified extracts that allow consumers to customize their cannabinoid intake based on specific wellness needs. Rare Cannabinoid Company operates primarily in the direct-to-consumer and wholesale markets, positioning itself as a leader in the minor cannabinoid sector of the hemp industry. The company emphasizes transparency through rigorous third-party testing and pharmaceutical-grade manufacturing standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rare Cannabinoid Company.